Dongdong Wu

Title: The Innovations of Dongdong Wu

Introduction

Dongdong Wu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of medicaments. With a total of 3 patents to his name, Wu's work focuses on innovative methods of treatment that have the potential to improve patient outcomes.

Latest Patents

One of Wu's latest patents involves the use of IL-22 dimer in the manufacture of a medicament for intravenous administration. This patent outlines methods for administering an IL-22 dimer to individuals, including humans, by intravenously delivering an effective amount of the dimer. The specified dosage ranges from about 2 µg/kg to about 200 µg/kg, with a preferred range of about 10 µg/kg to about 45 µg/kg. The patent also includes methods for treating diseases through these administration techniques, along with the provision of kits, unit dosages, and articles of manufacture for practical application.

Career Highlights

Throughout his career, Dongdong Wu has worked with notable companies in the biotechnology sector. He has been associated with Generon (Shanghai) Corporation Ltd. and Evive Biotechnology (Shanghai) Ltd. His experience in these organizations has contributed to his expertise and innovative capabilities in the field.

Collaborations

Wu has collaborated with several professionals in his field, including Yuliang Huang and Xiaoqiang Yan. These collaborations have likely enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Dongdong Wu's contributions to biotechnology through his patents and career experiences highlight his role as a significant inventor in the industry. His work on IL-22 dimer administration showcases the potential for advancements in medical treatments.